Drug development for childhood cancers – Authors' reply

Nicholas Bird, Nicole Scobie, Vickie Buenger, Martha Donoghue, Dominik Karres

Open source

DOI
10.1016/s2352-4642(26)00268-3
Published
2026-12
Container
The Lancet Child & Adolescent Health
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2352-4642-26-00268-3,
  title = {Drug development for childhood cancers – Authors' reply},
  author = {Nicholas Bird and Nicole Scobie and Vickie Buenger and Martha Donoghue and Dominik Karres},
  year = {2026},
  journal = {The Lancet Child \& Adolescent Health},
  doi = {10.1016/s2352-4642(26)00268-3},
  url = {https://doi.org/10.1016/s2352-4642(26)00268-3}
}

RIS

TY  - JOUR
TI  - Drug development for childhood cancers – Authors' reply
AU  - Nicholas Bird
AU  - Nicole Scobie
AU  - Vickie Buenger
AU  - Martha Donoghue
AU  - Dominik Karres
PY  - 2026
JO  - The Lancet Child & Adolescent Health
DO  - 10.1016/s2352-4642(26)00268-3
UR  - https://doi.org/10.1016/s2352-4642(26)00268-3
ER  - 

APA

Bird, N., Scobie, N., Buenger, V., Donoghue, M., & Karres, D. (2026). Drug development for childhood cancers – Authors' reply. The Lancet Child & Adolescent Health. https://doi.org/10.1016/s2352-4642(26)00268-3

Source records